Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Appraising organised screening programmes for testing for genetic susceptibility to cancer.

Authors: W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal: JAMA Date: 1997-03-19 Impact factor: 56.272

10. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

Authors:
Journal: Hum Reprod Date: 1997-09 Impact factor: 6.918

7 in total

1. Costs of prophylactic resection.

Authors: Terence J Colgan; Robert H Riddell; Aaron Pollett
Journal: CMAJ Date: 2003-07-22 Impact factor: 8.262

2. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

Authors: Anne Andermann; Ingeborg Blancquaert; Sylvie Beauchamp; Véronique Déry
Journal: Bull World Health Organ Date: 2008-04 Impact factor: 9.408

Review 3. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors: Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal: Eur J Hum Genet Date: 2011-04 Impact factor: 4.246

Appraising organised screening programmes for testing for genetic susceptibility to cancer.

Review 1. When can a risk factor be used as a worthwhile screening test?

2. Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled.

Review 3. ABC of colorectal cancer: screening.

Review 4. ABC of colorectal cancer. The role of clinical genetics in management.

Review 5. ABC of colorectal cancer. Molecular basis for risk factors.

Review 6. The new genetics in clinical practice.

7. Population screening for genetic susceptibility to disease.

8. Assessing the effectiveness of community screening programs.

Review 9. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

10. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

1. Costs of prophylactic resection.

2. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

Review 3. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

4. ECG screening of newborns to avoid sudden infant death syndrome?

5. Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.

6. How is genetic testing evaluated? A systematic review of the literature.

Review 7. The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss.